Calif. will require doctors to check prescription drug databases

Before prescribing potentially addictive drugs, California physicians will be required to check whether patients have gotten the same drugs from other doctors in the state.

The requirement was signed into law by California Gov. Jerry Brown. Prescribers will have to check the state’s prescription drug monitoring database before writing the initial prescription and then every four months for as long as the drug regimen continues. Medical boards will be responsible for enforcing the law, but there's no requirement for prescribers to withhold medication.

Advocates for the law like Bob Pack argued it’s still a useful tool to prevent patients from “doctor shopping,” because while the database has existed for years, he said few physicians elected to use it.

“Too many doctors for too long refused to use this lifesaving tool,” said Pack, who has been advocating for the database since two of his children were killed in 2003 by a driver under the influence of prescription drugs and alcohol. "Patients will be safer because of this legislation. Every doctor in California will have the information they need to safely prescribe potentially addictive drugs, curb the opioid abuse crisis and prevent prescription tragedies."

All states except Missouri have similar databases. More than 20 now require physicians to check them before writing prescriptions.

Being forced to use the database has changed prescribing habits in other states, according to the group Consumer Watchdog. It cited a survey of Tennessee physicians where 41 percent said they were less likely to prescribe opioids after checking the database.

The requirement will go into effect six month after the California Department of Justice certifies it’s prepared to handle the additional traffic as physicians check the database, according to KQED.  

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup